<DOC>
	<DOC>NCT01093417</DOC>
	<brief_summary>The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).</brief_summary>
	<brief_title>Study of Vitamin D and Effect on Heart Disease and Insulin Resistance</brief_title>
	<detailed_description>Randomized placebo controlled trial of vitamin D supplementation in HIV infected subjects with vitamin D deficiency</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>HIV infected HIVRNA &lt; 400 copies/ml at study entry and for 12 wks. prior 25hydroxyvitamin D level &lt;20 On a stable antiretroviral (ARV) regimen for at least 12 weeks prior to study entry Pregnancy or Breast Feeding Diabetes Creatinine Clearance &lt;50 Any active infectious or inflammatory condition aspartate aminotransferase (AST) or alanine aminotransferase (ALT) &gt;2.5 within 6 months prior to study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Human Immunodeficiency Virus (HIV)</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>